Jennison Associates LLC Buys 58,472 Shares of Teladoc Health, Inc. $TDOC

Jennison Associates LLC grew its stake in Teladoc Health, Inc. (NYSE:TDOC) by 58.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 158,832 shares of the health services provider’s stock after acquiring an additional 58,472 shares during the period. Jennison Associates LLC owned 0.09% of Teladoc Health worth $866,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Creative Planning boosted its holdings in shares of Teladoc Health by 7.7% in the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock valued at $159,000 after purchasing an additional 1,462 shares during the period. Syon Capital LLC increased its holdings in Teladoc Health by 19.1% during the 4th quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock worth $99,000 after purchasing an additional 2,264 shares during the period. ProShare Advisors LLC raised its position in Teladoc Health by 8.2% during the 4th quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider’s stock valued at $228,000 after purchasing an additional 2,457 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares in the last quarter. Finally, HighTower Advisors LLC lifted its holdings in shares of Teladoc Health by 19.2% in the 4th quarter. HighTower Advisors LLC now owns 18,647 shares of the health services provider’s stock worth $131,000 after buying an additional 2,997 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 8.2%

TDOC opened at $8.91 on Thursday. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -9.19 and a beta of 2.10. Teladoc Health, Inc. has a 12 month low of $4.40 and a 12 month high of $9.89. The stock has a fifty day moving average price of $7.96 and a 200-day moving average price of $6.50.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. During the same period in the previous year, the business earned ($0.53) EPS. Teladoc Health’s revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, equities research analysts anticipate that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Barclays cut their price target on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 26th. Citigroup upped their price objective on shares of Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 5th. Bank of America increased their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a report on Tuesday, July 7th. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, May 22nd. Finally, Canaccord Genuity Group boosted their price target on shares of Teladoc Health from $10.00 to $11.00 and gave the company a “buy” rating in a report on Tuesday. Five investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $7.73.

Insider Activity

In other news, CEO Charles Divita III sold 19,132 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $145,977.16. Following the transaction, the chief executive officer owned 389,894 shares of the company’s stock, valued at $2,974,891.22. The trade was a 4.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the transaction, the insider owned 9,572 shares of the company’s stock, valued at approximately $73,034.36. This trade represents a 37.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 39,195 shares of company stock valued at $299,058 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.